Trade receivables ageing (` cr) No. Particulars As at March 31, 2025 Outstanding for following period from due date Not due Less than 6 months 6 months- 1 year 1-2 years 2-3 years More than 3 years Total 1. Undisputed trade receivables: considered good 929.30 197.17 0.35 0.05 0.06 0.04 1,126.97 2. Undisputed trade receivables: which have significant increase in credit risk - 1.08 2.02 5.08 3.73 2.66 14.57 3. Disputed trade receivables: which have significant increase in credit risk - - - - - 1.03 1.03 Allowance for doubtful debts* - - (1.80) (6.99) (3.81) (3.71) (16.31) 929.30 198.25 0.57 (1.86) (0.02) 0.02 1,126.26 *Allowance for doubtful debts include expected credit loss provision. (` cr) No. Particulars As at March 31, 2024 Outstanding for following period from due date Not Due Less than 6 months 6 months- 1 year 1-2 years 2-3 years More than 3 years Total 1. Undisputed trade receivables: considered good 784.09 143.39 - - - - 927.48 2. Undisputed trade receivables: which have significant increase in credit risk - - 3.10 5.93 2.21 2.98 14.22 3. Disputed trade receivables: which have significant increase in credit risk - - - - - 0.99 0.99 Allowance for doubtful debts* - (0.58) (2.97) (5.92) (2.21) (3.97) (15.65) 784.09 142.81 0.13 0.01 - - 927.04 *Allowance for doubtful debts include expected credit loss provision. (` cr) Note 12 Cash and cash equivalents As at March 31, 2025 As at March 31, 2024 a) Balances with banks In current accounts 51.18 60.00 b) Cash on hand 0.19 0.26 51.37 60.26 There are no repatriation restrictions with regard to cash and cash equivalents. (` cr) Note 13 Bank balances other than cash and cash equivalents above As at March 31, 2025 As at March 31, 2024 a) Earmarked unclaimed dividend 2.64 2.67 b) Unclaimed interest on public deposit 0.00 0.00 c) Short-term bank deposit with maturity between 3 to 12 months 10.65 9.37 13.29 12.04 Note 11 Trade receivables (continued) 261 261 Corporate overview Performance overview ESG overview Statutory Reports Financial Statements
RkJQdWJsaXNoZXIy MjA2MDI2